Reliq Health Price To Sales Ratio Over Time

RHT Stock  CAD 0.22  0.00  0.00%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Reliq Health Performance and Reliq Health Correlation.
  
Price To Sales Ratio is likely to climb to 279.47 in 2024.
Please note, there is a significant difference between Reliq Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Reliq Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reliq Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Cross Equities Price To Sales Ratio Analysis

Compare Reliq Health Technologies and related stocks such as Premium Income, E L Financial, and Fairfax Financial Price To Sales Ratio Over Time
Select Fundamental
Price To Sales RatioPtb Ratio
Days Sales OutstandingBook Value Per Share
Free Cash Flow YieldInvested Capital
Operating Cash Flow Per ShareAverage Payables
Stock Based Compensation To RevenueCapex To Depreciation
Pb RatioEv To Sales
Free Cash Flow Per ShareRoic
Inventory TurnoverNet Income Per Share
Days Of Inventory On HandPayables Turnover
Sales General And Administrative To RevenueAverage Inventory
Research And Ddevelopement To RevenueCapex To Revenue
Cash Per SharePocfratio
Interest CoveragePayout Ratio
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingNet Current Asset Value
Income QualityRoe
Tangible Asset ValueEv To Operating Cash Flow
Pe RatioReturn On Tangible Assets
Ev To Free Cash FlowIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Dividend YieldEarnings Yield
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Cash Conversion Cycle
201020112012201320142015201620172018201920202021202220232024
PIC-A5.47279.49283.04613.6121(8.8131)4.35752.9054(15.4825)5.1316(1.4589)1.23332.9423(2.8165)(3.24)(3.08)
ELF0.30630.47670.61391.79541.13371.39791.7171.36932.99921.121.12621.4148(4.4917)1.31561.38
FFH1.60111.16790.91691.38881.11891.1131.19590.89840.73380.59580.59740.52350.58080.73230.98

Reliq Health Technologies and related stocks such as Premium Income, E L Financial, and Fairfax Financial Price To Sales Ratio description

Price to Sales Ratio is figured by comparing Reliq Health Technologies stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Reliq Health sales, a figure that is much harder to manipulate than other Reliq Health Technologies multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

My Equities

My Current Equities and Potential Positions

Reliq Health Technologies
RHT
ClassificationHealth Management
Business Address175 Longwood Rd
ExchangeTSX Venture Exchange
CAD 0.22

Additional Tools for Reliq Stock Analysis

When running Reliq Health's price analysis, check to measure Reliq Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reliq Health is operating at the current time. Most of Reliq Health's value examination focuses on studying past and present price action to predict the probability of Reliq Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reliq Health's price. Additionally, you may evaluate how the addition of Reliq Health to your portfolios can decrease your overall portfolio volatility.